What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks-Reference-Cited by-同舟云学术

What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks

Published:2020 Issue:45 Volume:49 Page:16004-16033
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

de Paiva Raphael E. F.¹²³⁴⁵^ORCID,Marçal Neto Antônio⁶⁷⁸⁹⁵^ORCID,Santos Igor A.¹⁰¹¹⁸⁹⁵^ORCID,Jardim Ana C. G.¹⁰¹¹⁸⁹⁵^ORCID,Corbi Pedro P.²¹²¹³⁵,Bergamini Fernando R. G.⁶⁷⁸⁹⁵^ORCID

Affiliation:

1. Department of Fundamental Chemistry

2. Institute of Chemistry

3. University of Sao Paulo

4. Sao Paulo

5. Brazil

6. Laboratory of Synthesis of Bioinspired Molecules

7. Institute do Chemistry

8. Federal University of Uberlândia

9. Uberlândia

10. Laboratory of Virology

11. Institute of Biomedical Sciences

12. University of Campinas

13. Campinas

Abstract

Despite a significative classical literature, metallodrugs have struggled to reach clinical practice. In light of the COVID-19 outbreak, this review aims at further encouraging and promoting the development of metallodrugs as viable antiviral agents.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Royal Society

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/D0DT02478C

Reference175 articles.